Literature DB >> 16273789

Assessment of pain in rheumatic diseases.

T Sokka1.   

Abstract

Pain is the most prominent symptom in people with musculoskeletal disorders, and the most common motivation for patients seeking medical help. However, pain generally is not recorded quantitatively in routine medical care. Over the last three decades, self-report questionnaires have been developed in which a patient may record quantitatively a pain score at baseline and over time to determine whether their condition has improved, remains unchanged, or has worsened. The most robust quantitative pain measure appears to be a simple 10 cm visual analog scale (VAS), which can be completed by the patient and scored by a health professional in less than 10 seconds. Quantitative data concerning pain cannot be obtained from any source other than the patient. Quantitative assessment of pain at each visit in routine rheumatology care, along with the assessment of functional disability, global status, and other patient variables, using a patient self-report questionnaire might lead to improved patient care.

Entities:  

Mesh:

Year:  2005        PMID: 16273789

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  11 in total

Review 1.  Biomarkers to guide clinical therapeutics in rheumatology?

Authors:  William H Robinson; Rong Mao
Journal:  Curr Opin Rheumatol       Date:  2016-03       Impact factor: 5.006

2.  The concomitant consumption of cod liver oil causes a reduction in the daily diclofenac sodium usage in rheumatoid arthritis patients: a pilot study.

Authors:  Vinay Kumar Gupta; Z Y Zafer Khan; Mushtaq Ahmad
Journal:  J Clin Diagn Res       Date:  2013-05-28

3.  Pain threshold and intensity in rheumatic patients: correlations with the Hamilton Depression Rating scale.

Authors:  Gianluca Bagnato; Ilenia De Andres; Stefania Sorbara; Elisa Verduci; Giorgio Corallo; Antonino Ferrera; Salvatore Morgante; William Neal Roberts; Gianfilippo Bagnato
Journal:  Clin Rheumatol       Date:  2014-01-10       Impact factor: 2.980

4.  The efficacy of Xialine in patients with Sjögren's syndrome: a single-blind, cross-over study.

Authors:  Esin Alpöz; Pelin Güneri; Gonca Onder; Hülya Cankaya; Yasemin Kabasakal; Timur Köse
Journal:  Clin Oral Investig       Date:  2007-11-14       Impact factor: 3.573

5.  Validation and relevance of Rheumatoid Arthritis Pain Scale (RAPS) in Indian (Asian) patients suffering from rheumatoid arthritis.

Authors:  Toktam Kianifard; Taghi Kianyfard; Arvind Chopra
Journal:  Clin Rheumatol       Date:  2015-09-12       Impact factor: 2.980

6.  Satisfaction with access to health services: the perspective of Estonian patients with rheumatoid arthritis.

Authors:  Kaja Põlluste; Riina Kallikorm; Kersti Meiesaar; Margus Lember
Journal:  ScientificWorldJournal       Date:  2012-04-19

7.  Impact of the Arthritis Foundation's Walk With Ease Program on arthritis symptoms in African Americans.

Authors:  Brooke Wyatt; Chivon A Mingo; Mary B Waterman; Patience White; Rebecca J Cleveland; Leigh F Callahan
Journal:  Prev Chronic Dis       Date:  2014-11-13       Impact factor: 2.830

Review 8.  Sustained remission in rheumatoid arthritis: latest evidence and clinical considerations.

Authors:  Sofia Ajeganova; Tom Huizinga
Journal:  Ther Adv Musculoskelet Dis       Date:  2017-08-02       Impact factor: 5.346

9.  Patients with severe low back pain exhibit a low level of physical activity before lumbar fusion surgery: a cross-sectional study.

Authors:  Hanna Lotzke; Max Jakobsson; Annelie Gutke; Maria Hagströmer; Helena Brisby; Olle Hägg; Rob Smeets; Mari Lundberg
Journal:  BMC Musculoskelet Disord       Date:  2018-10-11       Impact factor: 2.362

10.  Changes in Opioid Utilization Following Tumor Necrosis Factor Inhibitor Initiation in Patients with Rheumatoid Arthritis.

Authors:  Siyeon Park; Tham T Le; Julia F Slejko; Ester Villalonga-Olives; Eberechukwu Onukwugha
Journal:  Rheumatol Ther       Date:  2019-10-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.